• SENSEX
    NIFTY 50
Healthcare

AstraZeneca Pharma shares surge 13% after parent company resumes vaccine trials in UK

Updated : September 14, 2020 01:24 PM IST

Its parent company said that it has resumed British clinical trials of its COVID-19 vaccine.
The stock rose as much as 13 percent to Rs 4,546 per share.
AstraZeneca Pharma shares surge 13% after parent company resumes vaccine trials in UK

You May Also Like

Live TV
Advertisement